Heart failure treatment appears to reduce atrial fibrillation in Type 2 diabetes
Article written by Bruce Sylvester A new meta-analysis of clinical trial data suggests that sodium-glucose cotransporter 2 inhibitors (SGLT2), used to treat heart failure, also reduce the risk… read more.